Menu Search
Equities

Elan Corp

6099:TYO

Elan Corp

Actions
Health CareHealth Care Providers
  • Price (JPY)699.00
  • Today's Change-11.00 / -1.55%
  • Shares traded192.10k
  • 1 Year change-28.89%
  • Beta1.4348
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in JPY

The one analyst offering a 12 month price target expects Elan Corp share price to rise to 1,000.00 in the next year from the last price of 699.00.
High43.1%1,000.00
Med43.1%1,000.00
Low43.1%1,000.00

Dividends in JPY

In 2023, Elan Corp reported a dividend of 13.00 JPY, which represents a 18.18% increase over last year. The analyst covering the company expects dividends of 14.00 JPY for the upcoming fiscal year, an increase of 7.69%.
Div growth (TTM)18.18%
More ▼

Earnings history & estimates in JPY

Elan Corp reported annual 2023 earnings of 41.66 per share on Feb 13, 2024.
Average growth rate+27.11%
More ▼

Revenue history & estimates in JPY

Elan Corporation had revenues for the full year 2023 of 41.43m. This was 14.23% above the prior year's results.
Average growth rate+17.84%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.